Contamination ways of Human Immunodeficiency Virus (HIV) and Risk Gruops of AIDS
[HUMAN IMMUNODEFICIENCY VIRUS (HIV)'UN BULAŞ YOLLARI VE AIDS'IN RiSK GRUPLARI]
Abstract views: 59 / PDF downloads: 56
DOI:
https://doi.org/10.58600/eurjther-199342-1122-xKeywords:
HIV, Contamination way, AIDS, Risk groupsAbstract
In this report, the knowledges about, HN infections which is closely concerning of social health are reviewed. At the moment was dwelled on HN's contamination ways and AIDS' risk groups. For an effective struggle with AIDS, especially homosexuals, i.v. drug users, transfused people and heamophiliac people should be especially inspected.
Metrics
References
Şatırlar N.:Türkiye'de AIDS epidemisinin durumu. 1.Türkiye AIDS Kongresi-İstanbul (12-15 Ocak 1993) Kongre Kitabı. Okaş Ofset, s:51-54.
Sağlık Bakanlığı Notlan:30.9.1993 tarihi itibariyle Tıirkiye'de AIDS vakalan ve HIV enfeksiyonlannın yıllara göre dağılımı.
Centers for Disease Control:Up date:Acquired irnmunodeficiency syndrome in the SanFrancisco cohort study MMWR 34:573, 1985.
Altay G.:AIDS:Acquired irnmunodeficiency syndrome:Sonradan kazanılmış irnmıin yetmezlik sendromu. Mikrobiyol Bıilt 14:238, 1985.
Centers for Disesase Control:Tuberculosis and acquired irnmunodeficiency syndrome. New York city rnortayt and norbidity. Weekly report. JAMA 36:338, 1987.
Akın A.:AIDS hastalığının bulaşma yollan ve hastalıkta görıilen klinik bulgular. Ankara Eczacı odası Bıilt.9:36, 1987.
Badur S., Çelik G.:AIDS'in seroepidemiyolojisi. Klimik Derg 1:33, 1988.
Kingsley LA.:Risk factors for seroconversion to human irnmunodeficiency virus arnong male homesexuals. Lancet 1:345, 1987.
Hacıbektaşoğlu A., Pahsa A.:Seroepidemical survey of Anti-HIV positivity in Turkey. Med Corps International 5:18, 1990.
Demiröz P., Hacıbektaşoğlu A., Irmak H., Kocabalkan F., Baysal B.:Partikıil aglutinasyon testi ile HIV antikorlannın belirlenmesi ve diğer yöntemlerle karşılaşbnlması. ·Lepr Mec. 21:92, 1990.
Heyward WL., Curran JN.:The epidemiology of AIDS in the U.S.Sci Am 259:52, 1988.
Mann JM., Chin J., et al.:The international epidemiology of AIDS Sci Am 259:60, 1988.
Kaldor J., Mc Donald AM., Blumer CE., Gerting DM., et al.:The acquired irnmunodeficiency syndrome in Australia:Incidence 1982-1991. Med J Aust 153:10, 1993.
Gertig D., Crofts N., Stevenson E., Brechkin A.:The epidemiology of HIV-I infection in Victoria, Med J Aust 158:17, 1993.
D' Aquila RT., Williams AB.:Epidemic human irnmunodeficiency virus (HIV) infection among intravenous drug users (IVDU). Yale J Biol Med 60:545, 1987.
Okuyan M.:AIDS epidemiyolojisi. AIDS Paneli, Logus Yayıncılık, İzmir, s:5, 1987.
Lifson AR., Augelle RA., et al.:The epidemiology of AIDS world wide. Oin Imm Alg 6:441, 1986.
Çetin ET.:Sağlık Bakanlığı verileri(29.2.1992) AIDS Savaşım Bıilt 2:3, 1992
Atamer-Şirnşek Ş.:Damar içi uyuşturucu kullananlarda AIDS 1.Tıirkiye AIDS Kongresiİstanbul( 12-15 Ocak 1993) Kongre Kitabı, Omaş Ofset s:62
Guinan ME., Hardy A.:Epidemiology of AIDS in women in the United States. JAMA 257:2039, 1987.
Steward GJ., Tyler JPP., Cunningham AL., et al.:Transmission of human T İymphocyte virus type III (HTLV-III) by artifical insemination by donor. Lancet 2:581, 1985.
Bozkaya E.:Kadın ve AIDS, 1.Turkiye AIDS Kongresi-İstanbu1(12-14 Ocak 1993) Kongre Kitabı, Omaş Ofset, s:55.
Oktay İ.:Kadın ve AIDS. 1.Türkiye Kongresi-İstanbu1(12-15 Ocak 1993) Kongre Kitabı, Omaş Ofset, s:55.
Sezer RE, Kılıç S. :Elazığ'da Fırat Üniversitesi Hastanesinde kan veren gönüllülerde ve hayat kadınlarınd Anti-HIV, HBsAg taraması İl Ulusal Halk Sağlığı Kongresi-İstanbul (22-25 Mayıs 1990) Bildiri Özet Kitabı, İstanbul Tıp Fakültesi
Balıkçı E., Turhanoğlu H., Arıkan E. :Bazı gruplardan AntiHIV antikorlarının araştırılması, İnfeksiyon Derg(Baskıda)
Lapointe N., Michaud S., Pekovic D. et all.: Transplesantal transmission of HTLV-III. N Eng J Med 312:1325, 1985.
Perre VP., Clumeck N., Careal M., et al.:Female protitutes:A risk group for infection with human T-tell lymphotropic virus type IİI. Lancet 2:524, 1985.
Mc Donald KL., Jackson Browman RJ., et al. :performance characteristics of serologic test for human immunodeficiency virus type 1 antibody among Minnesota bloods donors. Ann Intern Med 110: 617, 1989.
Leitman ST., Klein HG., Melpolder JJ, Read EJ. : Clinical implications of positive tests for antibodies to human immunodeficiency virus in asymptomatic blood donors. N Engl J Med 321:917, 1989.
Singul A., Pulmood RB., Jhon T., et all: The prevalence of markers for hepatitis B and human immonodeficiency virues in blood donors in a large hospital in South India. J. Trop Med Hyg 93:178, 1990.
Patıroğlu T., Kumandaş S.: Kan vericilerinde anti-HIV, sifiliz ve HBsAg taraması. İnfeksiyon Derg 5:155, 1991.
Colebunders R., Ryder R., Francis H., Nekwel., et all: Seroconversion rate, mortality ad clinical manifeztations associated with the receip of a human immunodeficency virus. İnfected blood transfusion in Kinshasa, Zaire. J Infect Dis 164:450, 1991.
Davis KC., Horsborg CR:, Hasiba U., et al.: Acquired immunodeficiency syhdrome in a patient with hemophlia. Ann. Intern Med 3:284, 1983.
Kreiss Jkb, Kitchen LW., Prince HF. et al.: Antibody to human T-lymphotropic virus type IIIin wives of hemophilla. Ann Intern Med 102:623, 1985.
Erbaydar S.: Risk faktörleri ve bulaşma yolları. 1. Türkiye AIDS Kongresi- İstanbul (12-15 Ocak 1993) Kongre Kitabı Omaş Ofset, s:1.
Hohnan RC, Phodes PH., Chorba TL., Evstt BL .: Survival of hemophillc males with acquired immunodeficiency sydrome with and withoud risk factors for AIDS other than hemophilla. Am. J Hematol 39:275, 1992.
Leads from the MMWR.Acquaired immunodeficiency syndrome (AIDS) among black and hisparics United States. JAMA 256:2799, 1986.
Demiröz P., Irmak H., Şengül A., Ceviz HA., Kocabalkan F.: Yurtdışında yaşayan vatandaşlarımızın HIV infeksiyonu yönünden incelenmesi. Mikrobiyol Bült 23:703, 1989.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.